NCT03524235
- Conditions
- Blood Protein Disorders, CLL, Cardiovascular Diseases, +28 more
- Locations
-
- Cedars Sinai Medical Center Los Angeles, California, United States
Clinical trial condition
Neoplasms, Plasma Cell
Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.
2,604 public trials
547 recruiting studies
Neoplasms, Plasma Cell trial results
NCT01093196
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease, +15 more
- Locations
-
- Division Of Hematology, A.O.U. Città della Salute e della Scienza di Torino Torino, TO, Italy
NCT01755975
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
- Locations
-
- Saint Francis/Mount Sinai Regional Cancer Center Hartford, Connecticut, United States
- University of Nebraska Medical Center Omaha, Nebraska, United States
- Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Cancer Center at Commack Commack, New York, United States
NCT03630042
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- Derriford Hospital, Univeristy Hospitals Plymouth NHS Trust Plymouth, Devon, United Kingdom
- Torbay and South Devon NHS Foundation Trust Torquay, Devon, United Kingdom
- Royal Bournemouth Hospital, University Hospitals Dorset NHS Foundation Trust Bournemouth, Dorset, United Kingdom
- St Bartholomew's Hospital, Barts Health NHS Trust London, Greater London, United Kingdom
NCT01091831
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino Torino, Italy
NCT05567887
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital Nagoya, Aichi-ken, Japan
- Japanese Foundation for Cancer Research Koto, Tokyo, Japan
- The Cancer Institute Hospital of JFCR Koto, Tokyo, Japan
- Yamagata University Hospital Yamagata, Japan
Completed
Venetoclax, Ixazomib Citrate, and Dexamethasone in Treating Patients with Relapsed Multiple Myeloma
NCT03399539
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
- Mayo Clinic Rochester, Minnesota, United States
- Siteman Cancer Center at Washington University St Louis, Missouri, United States
NCT04398485
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- University of California San Diego Moores Cancer Center La Jolla, California, United States
- Cedars-Sinai Medical Center Los Angeles, California, United States
- UCLA Rrmc Los Angeles, California, United States
- Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
NCT04615572
- Conditions
- Amyloidosis, Blood Protein Disorders, Hematologic Diseases, +16 more
- Locations
-
- University of California, Irvine Health Chao Family Comprehensive Cancer Center Orange, California, United States
- University of California, San Francisco San Francisco, California, United States
- University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States
- Tufts Medical Center Boston, Massachusetts, United States
Completed
A Study Comparing BGB-3111 and Ibrutinib in Participants With Waldenström's Macroglobulinemia (WM)
NCT03053440
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Mayo Clinic Phoenix Phoenix, Arizona, United States
- City of Hope National Medical Center Duarte, California, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States